Direct-Acting Antiviral Therapy Produces High SVR12 in HCV GT-1 Cirrhotic Patients Regardless of Baseline Characteristics

Article Information

DOI 
http://dx.doi.org/10.1177/155989771448013
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Brian Hoyle
  1. Michael Fried, MD
    1. University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015200
Jun 2015200
Jul 2015111
Aug 20151700
Sep 20158700
Oct 2015742
Nov 20157050
Total192103

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Direct-Acting Antiviral Therapy Produces High SVR12 in HCV GT-1 Cirrhotic Patients Regardless of Baseline Characteristics
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Liver Conditions
Hepatology Clinical Trials Viral Infections
Liver Conditions
Hepatology Clinical Trials
Hepatology
Viral Infections